A-81418

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameA-81418
Drug Alias NameA-81418ABT-418
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscle-type nicotinic acetylcholine receptor agonists
TargetsMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A